MolecuLight
Anil Amlani has extensive experience in senior executive roles within the medical device, satellite, and telecommunication industries. Anil has held positions as CEO, COO, CCO, and CFO, and has been successful in executing strategies, acquisitions, and restructuring initiatives. Anil has also achieved significant operational efficiencies, global geographic expansions, and successful exits. Amlani has over $500M in financing experience and has completed three significant exits. Anil'smost recent role was as CEO at MolecuLight Inc, where they have been since October 2017. Prior to this, they served as Executive in Residence at FACIT from April to September 2017. Amlani also held leadership positions at FUJIFILM SonoSite, VisualSonics, Protana Inc. (formerly MDS Proteomics Inc.), Cancom, TD, and AT&T Canada.
Anil Amlani's education history includes attending the Institute of Chartered Accountants of Ontario, where they obtained a C.A. degree. Anil also attended Mbale SS, though the duration and specific details of their education at this institution are not provided. Additionally, Anil Amlani studied at ICAEW, earning another C.A. degree.
This person is not in any teams
MolecuLight
Moleculight is developing a non-invasive optical technology that acquires images like standard point-and-shoot digital cameras. The device provides real-time bacteriological information which is otherwise unobtainable using industry-standard wound assessment techniques, including conventional white light visualization.The first application ofthis technology will be in the global wound care market where there is an urgent medical need and where MolecuLight can significantly improve outcomes by providing a rapid and accurate diagnosis.